Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

SEARCH RESULT FOR:
OBESITY-BUSINESS/
RTX15EF3
15 Nov. 2013
A view shows an insulin production line at Novo Nordisk's... more
OBESITY-BUSINESS/
RTX15EF3
15 Nov. 2013
Kalundborg, Denmark
A view shows an insulin production line at Novo Nordisk's plant in Kalundborg November 4, 2013. Picture taken November 4, 2013. Novo Nordisk's Kalundborg factory, 100 km west of Copenhagen, makes half the planet's insulin for diabetics, putting it on a list of global sites the United States sees as vital to its interests, according to a WikiLeaks cable in 2010. Soaring diabetes rates, driven by increasing obesity, have fuelled profits at the Danish company for two decades. But now the company wants to tackle obesity head on by launching a treatment specifically to help patients lose weight. To match Insight OBESITY-BUSINESS/
REUTERS/Fabian Bimmer (DENMARK - Tags: BUSINESS HEALTH)
Page
of 1
Sort by
Items per page
Display
Print
Refine your search